Filing Details
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 04, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:HRMY
Harmony Biosciences Holdings, Inc. (HRMY) Files Quarterly Report for Q0
Filing Details Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 04, 2026. The…
Market Context
Harmony Biosciences Holdings, Inc.'s stock currently trades at $38.78 with a market capitalization of $2.3B.
The 10-Q provides Harmony Biosciences Holdings, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Harmony Biosciences Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HRMY Stock Page
Frequently Asked Questions
Where can I read HRMY's SEC filings?
Browse all filings on our HRMY SEC filings page.
What types of SEC filings does Harmony Biosciences Holdings, Inc. file?
Public companies like Harmony Biosciences Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.